Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validation. - Schnappinger D; Berthel SJ; Boshoff HIM; Krieger IV; Sukheja P; Panda S; Rath S; Briggs K; Bian X; Rasheed S; Cleghorn LAT; Ghorpade S; et al. (EMBO molecular medicine, 2026)